Primary objective

To assess the efficacy of several specific treatments in preventing the progression of a documented SARS-CoV-2 infection towards severity (defined as the need for oxygen or death) in adults aged 40 years and over or adults with co-morbidities (obesity or known hypertension or diabetes) in sub-Saharan Africa.